FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2178676502> ?p ?o ?g. }

• W2178676502 endingPage "150" @default.
• W2178676502 startingPage "1" @default.
• W2178676502 abstract "Background Early goal-directed therapy (EGDT) is recommended in international guidance for the resuscitation of patients presenting with early septic shock. However, adoption has been limited and uncertainty remains over its clinical effectiveness and cost-effectiveness. Objectives The primary objective was to estimate the effect of EGDT compared with usual resuscitation on mortality at 90 days following randomisation and on incremental cost-effectiveness at 1 year. The secondary objectives were to compare EGDT with usual resuscitation for requirement for, and duration of, critical care unit organ support; length of stay in the emergency department (ED), critical care unit and acute hospital; health-related quality of life, resource use and costs at 90 days and at 1 year; all-cause mortality at 28 days, at acute hospital discharge and at 1 year; and estimated lifetime incremental cost-effectiveness. Design A pragmatic, open, multicentre, parallel-group randomised controlled trial with an integrated economic evaluation. Setting Fifty-six NHS hospitals in England. Participants A total of 1260 patients who presented at EDs with septic shock. Interventions EGDT ( n = 630) or usual resuscitation ( n = 630). Patients were randomly allocated 1 : 1. Main outcome measures All-cause mortality at 90 days after randomisation and incremental net benefit (at £20,000 per quality-adjusted life-year) at 1 year. Results Following withdrawals, data on 1243 (EGDT, n = 623; usual resuscitation, n = 620) patients were included in the analysis. By 90 days, 184 (29.5%) in the EGDT and 181 (29.2%) patients in the usual-resuscitation group had died [ p = 0.90; absolute risk reduction −0.3%, 95% confidence interval (CI) −5.4 to 4.7; relative risk 1.01, 95% CI 0.85 to 1.20]. Treatment intensity was greater for the EGDT group, indicated by the increased use of intravenous fluids, vasoactive drugs and red blood cell transfusions. Increased treatment intensity was reflected by significantly higher Sequential Organ Failure Assessment scores and more advanced cardiovascular support days in critical care for the EGDT group. At 1 year, the incremental net benefit for EGDT versus usual resuscitation was negative at −£725 (95% CI −£3000 to £1550). The probability that EGDT was more cost-effective than usual resuscitation was below 30%. There were no significant differences in any other secondary outcomes, including health-related quality of life, or adverse events. Limitations Recruitment was lower at weekends and out of hours. The intervention could not be blinded. Conclusions There was no significant difference in all-cause mortality at 90 days for EGDT compared with usual resuscitation among adults identified with early septic shock presenting to EDs in England. On average, costs were higher in the EGDT group than in the usual-resuscitation group while quality-adjusted life-years were similar in both groups; the probability that it is cost-effective is < 30%. Future work The ProMISe (Protocolised Management In Sepsis) trial completes the planned trio of evaluations of EGDT across the USA, Australasia and England; all have indicated that EGDT is not superior to usual resuscitation. Recognising that each of the three individual, large trials has limited power for evaluating potentially important subgroups, the harmonised approach adopted provides the opportunity to conduct an individual patient data meta-analysis, enhancing both knowledge and generalisability. Trial registration Current Controlled Trials ISRCTN36307479. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 19, No. 97. See the NIHR Journals Library website for further project information." @default.
• W2178676502 created "2016-06-24" @default.
• W2178676502 creator A5007271096 @default.
• W2178676502 creator A5011011959 @default.
• W2178676502 creator A5018247103 @default.
• W2178676502 creator A5022812090 @default.
• W2178676502 creator A5022826906 @default.
• W2178676502 creator A5027150219 @default.
• W2178676502 creator A5033214001 @default.
• W2178676502 creator A5046085176 @default.
• W2178676502 creator A5059004773 @default.
• W2178676502 creator A5069977894 @default.
• W2178676502 creator A5073654128 @default.
• W2178676502 creator A5076220171 @default.
• W2178676502 creator A5082689888 @default.
• W2178676502 creator A5086478476 @default.
• W2178676502 creator A5089836433 @default.
• W2178676502 date "2015-11-01" @default.
• W2178676502 modified "2023-10-15" @default.
• W2178676502 title "Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock" @default.
• W2178676502 cites W127034668 @default.
• W2178676502 cites W1534244230 @default.
• W2178676502 cites W1560556070 @default.
• W2178676502 cites W1566155680 @default.
• W2178676502 cites W1777231336 @default.
• W2178676502 cites W1898928487 @default.
• W2178676502 cites W1967278969 @default.
• W2178676502 cites W1968106809 @default.
• W2178676502 cites W1969829944 @default.
• W2178676502 cites W1970637339 @default.
• W2178676502 cites W1974423408 @default.
• W2178676502 cites W1990166011 @default.
• W2178676502 cites W1993389721 @default.
• W2178676502 cites W2015172904 @default.
• W2178676502 cites W2015329932 @default.
• W2178676502 cites W2022781679 @default.
• W2178676502 cites W2027141829 @default.
• W2178676502 cites W2029284686 @default.
• W2178676502 cites W2045012616 @default.
• W2178676502 cites W2049435123 @default.
• W2178676502 cites W2049770538 @default.
• W2178676502 cites W2059059346 @default.
• W2178676502 cites W2060902812 @default.
• W2178676502 cites W2071387829 @default.
• W2178676502 cites W2072776551 @default.
• W2178676502 cites W2081814119 @default.
• W2178676502 cites W2101082552 @default.
• W2178676502 cites W2104415072 @default.
• W2178676502 cites W2106534536 @default.
• W2178676502 cites W2116749187 @default.
• W2178676502 cites W2118249259 @default.
• W2178676502 cites W2119652256 @default.
• W2178676502 cites W2122317738 @default.
• W2178676502 cites W2125153033 @default.
• W2178676502 cites W2125647201 @default.
• W2178676502 cites W2126499930 @default.
• W2178676502 cites W2129827480 @default.
• W2178676502 cites W2134689623 @default.
• W2178676502 cites W2134843796 @default.
• W2178676502 cites W2136529928 @default.
• W2178676502 cites W2141876137 @default.
• W2178676502 cites W2144830469 @default.
• W2178676502 cites W2145577370 @default.
• W2178676502 cites W2149133507 @default.
• W2178676502 cites W2151355802 @default.
• W2178676502 cites W2157097901 @default.
• W2178676502 cites W2160691650 @default.
• W2178676502 cites W2163133927 @default.
• W2178676502 cites W2165721969 @default.
• W2178676502 cites W2401846040 @default.
• W2178676502 cites W2768146862 @default.
• W2178676502 cites W3017100980 @default.
• W2178676502 cites W3023757607 @default.
• W2178676502 cites W4235830381 @default.
• W2178676502 cites W4237666362 @default.
• W2178676502 cites W4245690870 @default.
• W2178676502 cites W4293242440 @default.
• W2178676502 doi "https://doi.org/10.3310/hta19970" @default.
• W2178676502 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4781482" @default.
• W2178676502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26597979" @default.
• W2178676502 hasPublicationYear "2015" @default.
• W2178676502 type Work @default.
• W2178676502 sameAs 2178676502 @default.
• W2178676502 citedByCount "71" @default.
• W2178676502 countsByYear W21786765022015 @default.
• W2178676502 countsByYear W21786765022016 @default.
• W2178676502 countsByYear W21786765022017 @default.
• W2178676502 countsByYear W21786765022018 @default.
• W2178676502 countsByYear W21786765022019 @default.
• W2178676502 countsByYear W21786765022020 @default.
• W2178676502 countsByYear W21786765022021 @default.
• W2178676502 countsByYear W21786765022022 @default.
• W2178676502 countsByYear W21786765022023 @default.
• W2178676502 crossrefType "journal-article" @default.
• W2178676502 hasAuthorship W2178676502A5007271096 @default.
• W2178676502 hasAuthorship W2178676502A5011011959 @default.
• W2178676502 hasAuthorship W2178676502A5018247103 @default.
• W2178676502 hasAuthorship W2178676502A5022812090 @default.

• next